CIK 0001438533
- Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 262383102
- Phone
- +1 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,495,607
- in 10 filings, $79.5M under 10b5-1 plans
Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
- Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
- ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
- Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
- Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-28 | Shkreli Martin Chief Executive Officer | Purchase | +43,000 | $18.67 | $803K | 2,880,222 |
| 2014-02-24 | Shkreli Martin Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2014-02-24 | Shkreli Martin Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2014-02-24 | Shkreli Martin Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2014-02-24 | Plotkin Horacio Chief Medical Officer | Grant or award | +100,000 | 102,200 | ||
| 2014-02-24 | PANOFF MARC L Chief Financial Officer | Grant or award | +100,000 | 221,100 | ||
| 2014-02-21 | Shkreli Martin Chief Executive Officer | Purchase | +100 | $17.20 | $2K | 2,837,222 |
| 2014-02-21 | Shkreli Martin Chief Executive Officer | Purchase | +1,600 | $17.56 | $28K | 2,837,122 |
| 2014-02-14 | Shkreli Martin Chief Executive Officer | Purchase | +3,500 | $14.60 | $51K | 2,835,522 |
| 2014-02-06 | Shkreli Martin Chief Executive Officer | Purchase | +2,000 | $9.92 | $20K | 2,832,022 |
| 2014-01-14 | Shkreli Martin Chief Executive Officer | Purchase | +8,000 | $10.84 | $87K | 2,830,022 |
| 2013-09-12 | Shkreli Martin Chief Executive Officer | Purchase | +5,556 | $4.50 | $25K | 2,665,596 |
| 2013-09-12 | Shkreli Martin Chief Executive Officer | Other acquisition | +2,904 | 2,668,500 | ||
| 2013-09-12 | Shkreli Martin Chief Executive Officer | Purchase · Common Stock Purchase Warrants | +2,778 | 2,778 |
Page 59 of 59 · 1,174 trades